Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07248228 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 12 words
    • Publications: details revised at 1 of 1 entry
  2. Minor Start date changed from estimate of Jul 2026 to Jul 9, 2026v6
  3. Notable Recruitment opened
    • Site details revised
    v5
  4. Notable Start date: May 2026 to Jul 2026v4
  5. Notable Start date: Mar 2026 to May 2026v3
  6. Notable Start date: Dec 2025 to Mar 2026v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Participants in this research study have cancer that has spread to their brain, called brain metastases. One treatment for this type of cancer is called whole brain radiotherapy that stays away from a specific neurocognitive substructure, called the hippocampus, combined with medication to preserve cognitive function. This study compares that approach to another approach of whole brain radiotherapy that stays away from additional structures that are thought to have a role in cognitive function. Researchers want to see if there is a difference in the preservation of cognitive function between these two approaches.
Trial Details
NCT Number NCT07248228
Lead Sponsor Case Comprehensive Cancer Center
Conditions
(from sponsor)
Brain Metastases
Related terms Brain Neoplasms
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov